FTY720 attenuates APAP‑induced liver injury via the JAK2/STAT3 signaling pathway

He,Xiangmin; He,Xiangmin; He,Xiangmin; He,Xiangmin; He,Xiangmin; Kang,Kai; Kang,Kai; Kang,Kai; Kang,Kai; Kang,Kai; Pan,Dan; Pan,Dan; Pan,Dan; Pan,Dan; Pan,Dan; Sun,Yue; Sun,Yue; Sun,Yue; Sun,Yue; Sun,Yue; Chang,Bing; Chang,Bing; Chang,Bing; Chang,Bing; Chang,Bing

doi:10.3892/ijmm.2022.5123

FTY720 attenuates APAP‑induced liver injury via the JAK2/STAT3 signaling pathway

Authors:
- Xiangmin He
- Kai Kang
- Dan Pan
- Yue Sun
- Bing Chang
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110000, P.R. China, Department of Gastroenterology, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110000, P.R. China, Department of Geriatrics, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110000, P.R. China
Published online on: March 17, 2022 https://doi.org/10.3892/ijmm.2022.5123
Article Number: 67
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As the current clinical treatment of acetaminophen (APAP)‑induced liver injury (AILI) has its limitations, new and effective treatment methods are required. Fingolimod (FTY720) is an immunosuppressive drug developed in recent years that has been shown to have a protective effect against ischemia/reperfusion liver injury. However, the role of FTY720 in AILI remains unclear. The aim of the present study was to determine whether FTY720 has a protective effect on AILI. AILI was induced using intraperitoneal injection of 300 mg/kg APAP in male C57BL/6J mice. Following APAP challenge, the mice were administered 5 mg/kg FTY720 for 30 min. Protein expression levels were measured using western blot analysis. Cell viability was examined using Cell Counting Kit‑8 assays. mRNA levels were measured using reverse transcription‑quantitative PCR. Inflammation levels were evaluated using immunohistochemistry. Cell death and reactive oxygen species levels were examined using immunofluorescence. Furthermore, laser scanning intravital microscopy was used to directly observe immune cell recruitment. APAP treatment increased the serum levels of alanine transaminase and aspartate transaminase at the 6‑ and 12‑h time‑points, suggesting liver tissue damage. However, FTY720 attenuated the liver injury induced by APAP by reducing the recruitment of immune cells and the release of pro‑inflammatory cytokines and chemokines. FTY720 activated JAK2/STAT3 signaling and regulated the expression of BAX, BCL‑2 and p65 to inhibit apoptosis and inflammation. In addition, compared with APAP treatment, the viability of primary hepatocytes treated with APAP and FTY720 was increased. Inhibition of JAK2/STAT3 signaling attenuated the protective, antioxidant effects of FTY720. In conclusion, FTY720 reduced liver injury by regulating the JAK2/STAT3 signaling pathway. This compound was capable of inhibiting oxidative stress to reduce hepatocyte death and the infiltration of neutrophils in the liver.

View Figures

View References

1	Shan S, Shen Z and Song F: Autophagy and acetaminophen-induced hepatotoxicity. Arch Toxicol. 92:2153–2161. 2018. View Article : Google Scholar : PubMed/NCBI
2	[2] Bernal W and Wendon J: Acute liver failure. N Engl J Med. 369:2525–2534. 2013. View Article : Google Scholar : PubMed/NCBI
3	[3] Bunchorntavakul C and Reddy KR: Acetaminophen (APAP or N-Acetyl-p-Aminophenol) and acute liver failure. Clin Liver Dis. 22:325–346. 2018. View Article : Google Scholar : PubMed/NCBI
4	[4] Fisher ES and Curry SC: Evaluation and treatment of acetaminophen toxicity. Adv Pharmacol. 85:263–272. 2019. View Article : Google Scholar : PubMed/NCBI
5	[5] Jóźwiak-Bebenista M and Nowak JZ: Paracetamol: Mechanism of action, applications and safety concern. Acta Pol Pharm. 71:11–23. 2014.
6	[6] Ramachandran A and Jaeschke H: Acetaminophen toxicity: Novel insights into mechanisms and future perspectives. Gene Expr. 18:19–30. 2018. View Article : Google Scholar :
7	[7] Ramachandran A and Jaeschke H: Acetaminophen hepatotoxicity. Semin Liver Dis. 39:221–234. 2019. View Article : Google Scholar : PubMed/NCBI
8	[8] He Y, Feng D, Li M, Gao Y, Ramirez T, Cao H, Kim SJ, Yang Y, Cai Y, Ju C, et al: Hepatic mitochondrial DNA/Toll-like receptor 9/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice. Hepatology. 66:220–234. 2017. View Article : Google Scholar : PubMed/NCBI
9	[9] Guo XD, Ji J, Xue TF, Sun YQ, Guo RB, Cheng H and Sun XL: FTY720 exerts anti-glioma effects by regulating the glioma microenvironment through increased CXCR4 internalization by glioma-associated microglia. Front Immunol. 11:1782020. View Article : Google Scholar : PubMed/NCBI
10	[10] Dragun D, Fritsche L, Boehler T, Peters H, Budde K and Neumayer HH: FTY720: Early clinical experience. Transplant Proc. 36(2 Suppl): 544S–548S. 2004. View Article : Google Scholar : PubMed/NCBI
11	[11] Marciniak A, Camp SM, Garcia JGN and Polt R: An update on sphingosine-1-phosphate receptor 1 modulators. Bioorg Med Chem Lett. 28:3585–3591. 2018. View Article : Google Scholar : PubMed/NCBI
12	[12] Cheng X, Yeung PKK, Zhong K, Zilundu PLM, Zhou L and Chung SK: Astrocytic endothelin-1 overexpression promotes neural progenitor cells proliferation and differentiation into astrocytes via the Jak2/Stat3 pathway after stroke. J Neuroinflammation. 16:2272019. View Article : Google Scholar : PubMed/NCBI
13	[13] Jo S, Wang SE, Lee YL, Kang S, Lee B, Han J, Sung IH, Park YS, Bae SC and Kim TH: IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis. Arthritis Res Ther. 20:1152018. View Article : Google Scholar : PubMed/NCBI
14	[14] Zhang L and Wei W: Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 207:1074522020. View Article : Google Scholar
15	[15] Hata T, Rehman F, Hori T and Nguyen JH: GABA, γ-aminobutyric acid, protects against severe liver injury. J Surg Res. 236:172–183. 2019. View Article : Google Scholar : PubMed/NCBI
16	[16] Yu HC, Qin HY, He F, Wang L, Fu W, Liu D, Guo FC, Liang L, Dou KF and Han H: Canonical notch pathway protects hepatocytes from ischemia/reperfusion injury in mice by repressing reactive oxygen species production through JAK2/STAT3 signaling. Hepatology. 54:979–988. 2011. View Article : Google Scholar : PubMed/NCBI
17	[17] Zai W, Chen W, Luan J, Fan J, Zhang X, Wu Z, Ding T, Ju D and Liu H: Dihydroquercetin ameliorated acetaminophen-induced hepatic cytotoxicity via activating JAK2/STAT3 pathway and autophagy. Appl Microbiol Biotechnol. 102:1443–1453. 2018. View Article : Google Scholar
18	[18] Freitas MC, Uchida Y, Zhao D, Ke B, Busuttil RW and Kupiec-Weglinski JW: Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl. 16:600–610. 2010. View Article : Google Scholar : PubMed/NCBI
19	[19] Zhou HC, Wang H, Shi K, Li JM, Zong Y and Du R: Hepatoprotective effect of baicalein against acetaminophen-induced acute liver injury in mice. Molecules. 24:1312018. View Article : Google Scholar
20	[20] Hong SS, Choi JH, Lee SY, Park YH, Park KY, Lee JY, Kim J, Gajulapati V, Goo JI, Singh S, et al: A novel small-molecule inhibitor targeting the IL-6 receptor β subunit, glycoprotein 130. J Immunol. 195:237–245. 2015. View Article : Google Scholar : PubMed/NCBI
21	[21] Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, Arthur MJ, Iredale JP and Mann DA: Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology. 121:685–698. 2001. View Article : Google Scholar : PubMed/NCBI
22	[22] Liew PX, Lee WY and Kubes P: iNKT cells orchestrate a switch from inflammation to resolution of sterile liver injury. Immunity. 47:752–765.e5. 2017. View Article : Google Scholar : PubMed/NCBI
23	[23] Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	[24] Athersuch TJ, Antoine DJ, Boobis AR, Coen M, Daly AK, Possamai L, Nicholson JK and Wilson ID: Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: A perspective. Toxicol Res (Camb). 7:347–357. 2018. View Article : Google Scholar
25	[25] Mitchell JR, Jollow DJ, Potter WZ, Gillette JR and Brodie BB: Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 187:211–217. 1973.PubMed/NCBI
26	[26] Giustarini G, Kruijssen L, van Roest M, Bleumink R, Weaver RJ, Bol-Schoenmakers M, Smit J and Pieters R: Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice. J Appl Toxicol. 38:753–765. 2018. View Article : Google Scholar : PubMed/NCBI
27	[27] Lesiński W, Mnich K, Golińska AK and Rudnicki WR: Integration of human cell lines gene expression and chemical properties of drugs for drug induced liver injury prediction. Biol Direct. 16:22021. View Article : Google Scholar
28	[28] Kong X, Guo D, Liu S, Zhu Y and Yu C: Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control study. Br J Clin Pharmacol. 87:4304–4312. 2021. View Article : Google Scholar : PubMed/NCBI
29	[29] Katarey D and Verma S: Drug-induced liver injury. Clin Med (Lond). 16(Suppl 6): S104–S109. 2016. View Article : Google Scholar
30	[30] Fisher K, Vuppalanchi R and Saxena R: Drug-induced liver injury. Arch Pathol Lab Med. 139:876–887. 2015. View Article : Google Scholar : PubMed/NCBI
31	[31] Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, Xu J, Niu J, Liu J, Watkins PB, et al: Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology. 156:2230–2241.e11. 2019. View Article : Google Scholar : PubMed/NCBI
32	[32] Jaeschke H, Murray FJ, Monnot AD, Jacobson-Kram D, Cohen SM, Hardisty JF, Atillasoy E, Hermanowski-Vosatka A, Kuffner E, Wikoff D, et al: Assessment of the biochemical pathways for acetaminophen toxicity: Implications for its carcinogenic hazard potential. Regul Toxicol Pharmacol. 120:1048592021. View Article : Google Scholar : PubMed/NCBI
33	[33] Papp S, Moderzynski K, Rauch J, Heine L, Kuehl S, Richardt U, Mueller H, Fleischer B and Osterloh A: Liver necrosis and lethal systemic inflammation in a murine model of rickettsia typhi Infection: Role of neutrophils, macrophages and NK cells. PLoS Negl Trop Dis. 10:e00049352016. View Article : Google Scholar : PubMed/NCBI
34	[34] Ishitsuka Y, Kondo Y and Kadowaki D: Toxicological property of acetaminophen: The dark side of a safe antipyretic/analgesic drug. Biol Pharm Bull. 43:195–206. 2020. View Article : Google Scholar
35	[35] Zhang L, Gao H, Yang L, Liu T, Zhang Q, Xun J, Li C, Cui L and Wang X: FTY720 induces neutrophil extracellular traps via a NADPH oxidase-independent pathway. Arch Biochem Biophys. 711:1090152021. View Article : Google Scholar : PubMed/NCBI
36	[36] King A, Houlihan DD, Kavanagh D, Haldar D, Luu N, Owen A, Suresh S, Than NN, Reynolds G, Penny J, et al: Sphingosine-1-phosphate prevents egress of hematopoietic stem cells from liver to reduce fibrosis. Gastroenterology. 153:233–248.e16. 2017. View Article : Google Scholar : PubMed/NCBI
37	[37] Sharma N, Akhade AS and Qadri A: Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells. J Leukoc Biol. 93:521–528. 2013. View Article : Google Scholar : PubMed/NCBI
38	[38] Liang YJ, Luo J, Lu Q, Zhou Y, Wu HW, Zheng D, Ren YY, Sun KY, Wang Y and Zhang ZS: Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells. PLoS One. 7:e424902012. View Article : Google Scholar : PubMed/NCBI
39	[39] Herz J, Köster C, Crasmöller M, Abberger H, Hansen W, Felderhoff-Müser U and Bendix I: Peripheral T cell depletion by FTY720 exacerbates hypoxic-ischemic brain injury in neonatal mice. Front Immunol. 9:16962018. View Article : Google Scholar : PubMed/NCBI
40	[40] Sola A, Weigert A, Jung M, Vinuesa E, Brecht K, Weis N, Brüne B, Borregaard N and Hotter G: Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration. J Pathol. 225:597–608. 2011. View Article : Google Scholar : PubMed/NCBI
41	[41] Tsai HC and Han MH: Sphingosine-1-Phosphate (S1P) and S1P signaling pathway: Therapeutic targets in autoimmunity and inflammation. Drugs. 76:1067–1079. 2016. View Article : Google Scholar : PubMed/NCBI
42	[42] Zhao M, Yang C, Chai S, Yuan Y, Zhang J, Cao P, Wang Y, Xiao X, Wu K, Yan H, et al: Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways. Phytother Res. 35:2157–2170. 2021. View Article : Google Scholar
43	[43] Takai K, Takahara S, Isoyama N, Tsuchida M, Matsumura M, Kishi Y, Uchiyama K and Naito K: Effects of FTY720 on rat lymphoid organs. Transplant Proc. 36:2453–2456. 2004. View Article : Google Scholar : PubMed/NCBI
44	[44] Nagahara Y, Enosawa S, Ikekita M, Suzuki S and Shinomiya T: Evidence that FTY720 induces T cell apoptosis in vivo. Immunopharmacology. 48:75–85. 2000. View Article : Google Scholar
45	[45] Tuckermann JP, Kleiman A, McPherson KG and Reichardt HM: Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci. 42:71–104. 2005. View Article : Google Scholar : PubMed/NCBI
46	[46] Sordo-Bahamonde C, Lorenzo-Herrero S, Payer ÁR, Gonzalez S and López-Soto A: Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer. Int J Mol Sci. 21:37262020. View Article : Google Scholar :
47	[47] Jiang J, Huang X, Wang Y, Deng A and Zhou J: FTY720 induces cell cycle arrest and apoptosis of rat glomerular mesangial cells. Mol Biol Rep. 39:8243–8250. 2012. View Article : Google Scholar : PubMed/NCBI
48	[48] Chen J, Zhang C, Li S, Li Z, Lai X and Xia Q: Exosomes derived from nerve stem cells loaded with FTY720 promote the recovery after spinal cord injury in rats by PTEN/AKT signal pathway. J Immunol Res. 2021:81002982021. View Article : Google Scholar : PubMed/NCBI
49	[49] Hu Z, Han Y, Liu Y, Zhao Z, Ma F, Cui A, Zhang F, Liu Z, Xue Y, Bai J, et al: CREBZF as a key regulator of STAT3 pathway in the control of liver regeneration in mice. Hepatology. 71:1421–1436. 2020. View Article : Google Scholar
50	[50] Ozaki M: Cellular and molecular mechanisms of liver regeneration: Proliferation, growth, death and protection of hepatocytes. Semin Cell Dev Biol. 100:62–73. 2020. View Article : Google Scholar
51	[51] Zegeye MM, Lindkvist M, Fälker K, Kumawat AK, Paramel G, Grenegård M, Sirsjö A and Ljungberg LU: Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Cell Commun Signal. 16:552018. View Article : Google Scholar : PubMed/NCBI
52	[52] Foster AD, Vicente D, Clark N, Leonhardt C, Elster EA, Davis TA and Bradley MJ: FTY720 effects on inflammation and liver damage in a rat model of renal ischemia-reperfusion injury. Mediators Inflamm. 2019:34968362019. View Article : Google Scholar : PubMed/NCBI
53	[53] Zhao Y, Man K, Lo CM, Ng KT, Li XL, Sun CK, Lee TK, Dai XW and Fan ST: Attenuation of small-for-size liver graft injury by FTY720: Significance of cell-survival Akt signaling pathway. Am J Transplant. 4:1399–1407. 2004. View Article : Google Scholar : PubMed/NCBI
54	[54] Kaneko T, Murakami T, Kawana H, Takahashi M, Yasue T and Kobayashi E: Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced hepatic injury in mice. Biochem Biophys Res Commun. 345:85–92. 2006. View Article : Google Scholar : PubMed/NCBI